Why the study?
Does intra-arterial prostaglandin E1 increase superior mesenteric artery blood flow and enhance angiographic visualization in patients undergoing angiography?
Does intra-arterial prostaglandin E1 increase superior mesenteric artery blood flow and enhance angiographic visualization in patients undergoing angiography?
Intra-arterial administration of prostaglandin E1 during angiography significantly increases superior mesenteric artery blood flow and improves vessel visualization.
Hypothesis-generating for intra-arterial PGE1 in mesenteric angiography; should not change practice without controlled trials.
The hemodynamic effects of intra-material prostaglandin E1 (PE1) administered via the angiographic catheter were evaluated in 14 patients. Blood flow in the superior mesenteric artery (SMA) after PGE1 infusion was compared with control SMA blood flow as measured by the "spillover" angiographic reflux method, using a specially designed injector/film-changer system. In all patients, SMA blood flow increased by more than 50% and visualization of the SMA and portal vein was enhanced.
No takes yet. Share an insight, caveat, or question.
Clark et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: